Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Paragonix Technologies
- Study ID
- NCT05082077
- Status
- Enrolling By Invitation
Conditions
- Liver Diseases
- Liver Dysfunction
- Liver Transplant Disorder
- Liver Transplant Rejection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- LIVERguard — DEVICEThe LIVERguard is an FDA cleared and is a CE-marked medical device intended to be used for the static hypothermic preservation of livers during transportation and eventual transplantation into a recipient using cold storage solutions indicated for use with the liver. The intended organ storage time for the LIVERguard is up to 16 hours.
Study Details
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor liver that were preserved and transported within the LIVERguard system, as well as retrospective standard of care patients
Key Dates
- Start date
- Mar 15, 2022
- Status verified
- Jul 2024
- Primary completion
- Aug 31, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: LIVERguard patientPatients whose donor liver was transported with the LiverGuard device.
- Arm: Standard Transport PatientsPatients whose donor liver was transported with a method other than the LiverGuard
Primary Outcome Measure
Graft Failure [ Time Frame: Post-transplant through 1 year post ]
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | - |
| Stanford University | Stanford | California | 94305 | - |
| University of Florida | Gainesville | Florida | 32608 | - |
| Tampa General Hospital | Tampa | Florida | 33606 | - |
| University of Nebraska | Omaha | Nebraska | 68198 | - |
| Duke University | Durham | North Carolina | 27710 | - |
| University of Washington | Seattle | Washington | 98109 | - |
Find similar trials in Birmingham, AL
Related Studies
- DILIN - Prospective StudyRecruiting · Duke University · Los Angeles, California
- Diagnostic and Therapeutic Applications of Microarrays in Liver TransplantationRecruiting · University of Alberta · San Francisco, California
- Observational Pharmaco-Epidemiology Research & AnalysisRecruiting · Epividian · Durham, North Carolina
- Primary Sclerosing Cholangitis in ChildrenRecruiting · Arbor Research Collaborative for Health · Los Angeles, California